Samalin Investment Counsel, LLC
Position in KYTX — Kyverna Therapeutics, Inc.
CIK 1544366
CHAPPAQUA, NY
Position in KYTX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$103,311
New position
Shares Held
11,595
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#6
of 15 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Samalin Investment Counsel, LLC holds $218,633 across 2 Biotechnology names. KYTX ranks #2 (47.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTX |
Nkarta, Inc.
|
40,750 | $115,322 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
This page
|
11,595 | $103,311 |
All Filings in KYTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,311 | 11,595 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||